NCT06463743View on ClinicalTrials.gov

Metformin as an add-on or Monotherapy in Treatment of Aging People With Multiple Sclerosis (MS)

PHASE2Not yet recruitingINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

October 15, 2025

Primary Completion Date

January 1, 2027

Study Completion Date

June 1, 2027

Conditions

Multiple Sclerosis

Interventions

DRUG

metformin

metformin

DRUG

Placebo

Placebo

All Listed Sponsors

collaborator

National Center for Advancing Translational Sciences (NCATS)

NIH

lead

State University of New York at Buffalo

OTHER